6 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
and/or to implement a lead independent director in accordance with its determination that utilizing one or the other structure would be in the best interests … .
The lead independent director will receive additional cash compensation in the amount of $25,000 per year.
The chair and each member of the audit committee
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
per year.
Each lead independent director will receive a cash retainer in the amount of $25,000 per year.
The chairperson of the audit committee
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
in the amount of $40,000 per year.
Each lead independent director will receive a cash retainer in the amount of $25,000 per year.
The chairperson of the audit
S-1/A
EX-10.21
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
Directors:
Non-Employee Director:
Lead Independent Director:
Audit Committee Chair:
Compensation Committee Chair:
Nominating and Corporate Governance
S-1
EX-10.12
1hdoy54
25 Aug 23
IPO registration
5:03pm
- Prev
- 1
- Next